Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Volumetric Brain MRI Quantification in Early versus Late Onset Alzheimer’s Disease
Aging, Dementia, and Behavioral Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
7-003

Investigators report greater parietal tau deposition and alternate frontoparietal network involvement in EOAD with onset <65 years as compared with typical LOAD. 

To investigate whether brain MRI quantified volumes reflect distinctive differences among patients with Early Onset Alzheimer’s Disease (EOAD) as compared with those with Late Onset Alzheimer’s disease (LOAD).

This study investigated the clinical MRI scans of 45 persons with Clinically Probable AD with onset <65 years, and compared them to 32 with Clinically Probable AD with onset ≥65 years.  Brain volumes on their T1 MRI scans were quantified with a volumetric program, which calculates percentage differences from normative scans, and regional volumes as fraction of total intracranial volume (TIV) were compared between both groups. Cohen’s D effect sizes and receiver operating characteristic (ROC) analyses were performed.

When adjusted for age, patients with EOAD had significantly smaller parietal lobes (volumetric percentiles) than those with LOAD.  They also had decreased total white matter and right pallidum, whereas, LOAD had a smaller left putamen and hippocampus among other regions. ROC analysis showed an area under the curve (AUC) of 96.5% with brain region delineation of EOAD compared to LOAD. 

When adjusted for age-related differences, the MRI scans of the EOAD patients were significantly different than those for the LOAD patients. In particular, the EOAD patients had distinctly smaller parietal lobes, out of proportion to any other differences and consistent with increased distribution of neuropathology, particularly cortical neurofibrillary tangles, in EOAD compared to LOAD.  This study indicates the presence of parietal atrophy at less than 30% of normal on clinical MRI scans is suggestive of the diagnosis of EOAD.

Authors/Disclosures
Somayeh Meysami, MD (Pacific Neuroscience Institute, Providence Saint Johns Health Center)
PRESENTER
Dr. Meysami has nothing to disclose.
Cyrus A. Raji, MD, PhD (Washington University in St Louis) Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
No disclosure on file
Verna R. Porter, MD (Pacific Neuroscience Institute/Providence St. Johns Santa Monica) Dr. Porter has nothing to disclose.
No disclosure on file